<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="23290" whole_study_id="23290" phs="001411" v="1" p="1" createDate="2017-01-25T10:45:47-05:00" completedByGPADate="2017-01-30T12:47:57-05:00" modDate="2022-01-25T16:16:14-05:00" maxParentChildStudyModDate="2022-01-25T16:16:14-05:00" handle="ACCORD" num_participants="6112"><StudyInfo accession="phs001411.v1.p1" parentAccession="phs001411.v1.p1"><BioProject id="PRJNA394548" entrez_id="394548" type="bp_admin_access"/><BioProject id="PRJNA394549" entrez_id="394549" type="bp_data_submission"/><StudyNameEntrez>Action to Control Cardiovascular Risk in Diabetes (ACCORD) Clinical Trial</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="Yes"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>supporting_documents</StudyType><StudyType>dna</StudyType><StudyType>snp_array</StudyType><StudyType>array_derived_genotypes</StudyType><StudyType>analysis</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="MICHAEL_WAGNER" aid="2" auth="eRA" login="MICHAEL_WAGNER" fname="Michael" mname="" lname="Wagner" email="michael_wagner@unc.edu"><Role>PI</Role><Organization>UNIV OF NORTH CAROLINA CHAPEL HILL</Organization></Person><Person nedid="0012448749" aid="1" auth="cit" login="kirbyr" fname="Ruth Anne" mname="Elizabeth" lname="Kirby" email="kirbyr@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="JMYCHALE" aid="2" auth="eRA" login="JMYCHALE" fname="JOSYF" mname="" lname="MYCHALECKYJ" email="jcm6t@virginia.edu"><Role>PI_ASSIST</Role><Organization>UNIVERSITY OF VIRGINIA</Organization></Person><Person nedid="0013043239" aid="1" auth="cit" login="pretels" fname="Renate" mname="S" lname="Pretel" email="pretels@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011552437" aid="1" auth="cit" login="jawang" fname="Zhen" mname="Yuan" lname="Wang" email="zhen.wang@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Genotypes were generated with the support of grants from the NHLBI (HL110380, P.I. John Buse, and HL110400, P.I. Alessandro Doria). Collaboration between researchers at the University of North Carolina, North Carolina State University, The Joslin Diabetes Center, and the University of Virginia to compare and merge two independently generated genotype data sets was supported by a grant from the UNC CTSA (UL1TR001111, PI: John Buse).

Samples from which genotypes were generated and clinical data were collected as part of the ACCORD trial (ClinicalTrials.gov Identifier: NCT00000620), which was supported by the following contracts: N01HC95178, N01HC95179, N01HC95180, N01HC95181, N01HC95182, N01HC95183, and N01HC95184. 

The ACCORD study design was described in the following publication: ACCORD Study Group., Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol. 2007 Jun 18;99(12A):21i-33i. 

The consent process for genetic studies in ACCORD and the numbers of participants who consented may be found in:
Simons-Morton DG, Chan JC, Kimel AR, Linz PE, Stowe CL, Summerson J, Ambrosius WT. Characteristics associated with informed consent for genetic studies in the ACCORD trial. Contemp Clin Trials. 2014 Jan;37(1):155-64. doi: 10.1016/j.cct.2013.12.002.

We would like to thank the 10,251 subjects who participated in ACCORD, as well as the ACCORD clinical investigators at over 70 sites in the US and Canada.

We also extend our appreciation to the following industry contributors to ACCORD: Abbott Laboratories (Abbott Park, IL); Amylin Pharmaceutical (San Diego, CA); AstraZeneca Pharmaceuticals LP (Wilmington, DE); Bayer HealthCare LLC (Tarrytown, NY); Closer Healthcare Inc. (Tequesta, FL); GlaxoSmithKline Pharmaceuticals (Philadelphia, PA); King Pharmaceuticals, Inc. (Bristol, TN); Merck &amp; Co., Inc. (Whitehouse Station, NJ); Novartis Pharmaceuticals, Inc. (East Hanover, NJ); Novo Nordisk, Inc. (Princeton, NJ); Omron Healthcare, Inc. (Schaumburg, IL); Sanofi-Aventis U.S. (Bridgewater, NJ); Schering-Plough Corporation (Kenilworth, NJ).
</acknowledgement_statement><ic_specific_access_term>There are two consent groups for ACCORD: 1) Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry. Requestor must provide documentation of local IRB approval; and 2) Use of the data must be related to Cardiovascular Disease, Diabetes and Kidney Disease. Requestor must provide documentation of local IRB approval.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2401" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB)" name="HMB-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2402" CGType="cg_class_DS" title="Disease-Specific (Cardiovascular Disease, Diabetes and Kidney Disease, IRB)" name="DS-CDKD-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the data must be related to Cardiovascular Disease, Diabetes and Kidney Disease.
Requestor must provide documentation of local IRB approval.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>